STORY AT-A-GLANCE
- Ivermectin is an antiparasitic drug that may be even more useful against COVID-19 than hydroxychloroquine (HCQ). However, like HCQ, use of ivermectin has been globally suppressed, discouraged and even warned against, despite decades of safe use for other ailments
- In the U.S., the Frontline COVID-19 Critical Care Alliance (FLCCC) has been calling for widespread adoption of Ivermectin, both as a prophylactic and for the treatment of all phases of COVID-19
- What makes ivermectin particularly useful in COVID-19 is the fact that it works both in the initial viral phase of the illness, when antivirals are required, as well as in the inflammatory stage, when the viral load drops off and anti-inflammatories become necessary
- A scientific review funded by the WHO found ivermectin reduced COVID-19 deaths by 75%. It also increased viral clearance. A meta-analysis of a greater number of studies found a 68% reduction in deaths
- Despite robust scientific support for ivermectin, the WHO, the U.S. FDA and NIH all refuse to recommend the drug on grounds of insufficient evidence
